Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Enantioselective Chromatographic Analysis of Formoterol Fumarate using Chiral Mobile Phase Additives and Achiral Core-Shell Column

View through CrossRef
A simple, robust, cost-effective, and rapid RP-HPLC method was developed for the separation of enantiomers of formoterol. The separation was achieved by the chiral mobile phase additive technique on an achiral column. Formoterol is a bronchodilator that consists of 50:50 S, S-formoterol and R, R-formoterol. The bronchodilator activity is attributed to R, R-formoterol. Hence, it is important to develop a method to separate the enantiomers of formoterol. Various factors affecting enantiomeric resolution were investigated and optimized. The enantiomers of formoterol were successfully separated with a resolution of 2.57 with a run-time of 9 minutes. The method was validated in accordance with ICH guidelines. The validated method was successfully applied to the marketed formulation of arformoterol.
American Chemical Society (ACS)
Title: Enantioselective Chromatographic Analysis of Formoterol Fumarate using Chiral Mobile Phase Additives and Achiral Core-Shell Column
Description:
A simple, robust, cost-effective, and rapid RP-HPLC method was developed for the separation of enantiomers of formoterol.
The separation was achieved by the chiral mobile phase additive technique on an achiral column.
Formoterol is a bronchodilator that consists of 50:50 S, S-formoterol and R, R-formoterol.
The bronchodilator activity is attributed to R, R-formoterol.
Hence, it is important to develop a method to separate the enantiomers of formoterol.
Various factors affecting enantiomeric resolution were investigated and optimized.
The enantiomers of formoterol were successfully separated with a resolution of 2.
57 with a run-time of 9 minutes.
The method was validated in accordance with ICH guidelines.
The validated method was successfully applied to the marketed formulation of arformoterol.

Related Results

Advances on broadband and resonant chiral metasurfaces
Advances on broadband and resonant chiral metasurfaces
Abstract Chirality describes mirror symmetry breaking in geometric structures or certain physical quantities. The interaction between chiral structure and chiral ...
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
Lung function in chronic obstructive pulmonary disease (COPD) can be improved acutely by oral corticosteroids and bronchodilators. Whether clinical improvement can be maintained by...
Environmental Surveillance Protocols for Highly Pathogenic Avian Influenza (HPAI) v2
Environmental Surveillance Protocols for Highly Pathogenic Avian Influenza (HPAI) v2
EnvironmentalSurveillance Protocols for Highly Pathogenic Avian Influenza (HPAI) This comprehensive protocol suite enables systematic environmental surveillance for avian influenza...
Chiral liquid crystal-MOF composites for electrochemical recognition of enantiomers
Chiral liquid crystal-MOF composites for electrochemical recognition of enantiomers
Biological systems rely on the exclusive use of L-configured biomolecules for precise molecular recognition, whereas exposure to D-enantiomers can disrupt immune and metabolic proc...
Lectin C gene analysis v1
Lectin C gene analysis v1
Mammalian Tissue Total RNA Purification Protocol by GeneJET RNA Purification Kit (Thermo Scientific, USA) Before starting: • Supplement the required amount of Lysis Buffer with β-...
Chiral Ionic Liquids as Stationary Phases in Electrophoretic Separations
Chiral Ionic Liquids as Stationary Phases in Electrophoretic Separations
Ionic liquids (ILs) are exceptional solvents having melting points at or below 100 0C. They are completely made up of ions, often consisting of an organic cation and an inorganic o...
Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice
Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice
Roflumilast is approved as an add-on therapy for chronic obstructive pulmonary disease. The inflammation in chronic obstructive pulmonary disease is mainly neutrophilic, while in a...

Back to Top